149 related articles for article (PubMed ID: 36401232)
1. Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes.
Sun H; Wang X; Zhang X; Wang X; Tan C; Weng W; Zhang M; Ni S; Wang L; Huang D; Xu M; Sheng W
BMC Cancer; 2022 Nov; 22(1):1188. PubMed ID: 36401232
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway.
Huang B; Mu P; Yu Y; Zhu W; Jiang T; Deng R; Feng G; Wen J; Zhu X; Deng Y
Gastric Cancer; 2021 Jan; 24(1):72-84. PubMed ID: 32529327
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
4. FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer.
Zhao Z; Zhu Y
BMC Cancer; 2023 Jun; 23(1):507. PubMed ID: 37277751
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.
Huang HG; Tang XL; Huang XS; Zhou L; Hao YG; Zheng YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959
[TBL] [Abstract][Full Text] [Related]
6. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.
Matsukawa Y; Semba S; Kato H; Ito A; Yanagihara K; Yokozaki H
Cancer Sci; 2006 Jun; 97(6):484-91. PubMed ID: 16734726
[TBL] [Abstract][Full Text] [Related]
7. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
8. FOXM1-Dependent Transcriptional Regulation of EZH2 Induces Proliferation and Progression in Prostate Cancer.
Tian JH; Mu LJ; Wang MY; Zeng J; Long QZ; Bin-Guan ; Wang W; Jiang YM; Bai XJ; Du YF
Anticancer Agents Med Chem; 2021; 21(14):1835-1841. PubMed ID: 32735528
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
10. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer.
Li X; Tang D; Yao Y; Qi W; Liang J
Clin Exp Med; 2014 Nov; 14(4):447-55. PubMed ID: 24101296
[TBL] [Abstract][Full Text] [Related]
12. Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance.
Li X; Ma K; Song S; Shen F; Kuang T; Zhu Y; Liu Z
Clin Exp Med; 2018 Aug; 18(3):413-420. PubMed ID: 29804142
[TBL] [Abstract][Full Text] [Related]
13. Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer.
Gao LM; Wang F; Zheng Y; Fu ZZ; Zheng L; Chen LL
Pathol Oncol Res; 2019 Jan; 25(1):369-376. PubMed ID: 29134462
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.
Ma J; Qi G; Xu J; Ni H; Xu W; Ru G; Zhao Z; Xu W; He X
Oncol Lett; 2017 Dec; 14(6):7288-7296. PubMed ID: 29344165
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients.
Li X; Qi W; Yao R; Tang D; Liang J
Clin Transl Oncol; 2014 Mar; 16(3):307-14. PubMed ID: 23873251
[TBL] [Abstract][Full Text] [Related]
16. A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer.
Hsu CC; Liao WY; Chang KY; Chan TS; Huang PJ; Chiang CT; Shan YS; Cheng LH; Liao TY; Tsai KK
Gastric Cancer; 2021 May; 24(3):624-639. PubMed ID: 33515163
[TBL] [Abstract][Full Text] [Related]
17. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
[TBL] [Abstract][Full Text] [Related]
18. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer.
He LJ; Cai MY; Xu GL; Li JJ; Weng ZJ; Xu DZ; Luo GY; Zhu SL; Xie D
Asian Pac J Cancer Prev; 2012; 13(7):3173-8. PubMed ID: 22994729
[TBL] [Abstract][Full Text] [Related]
20. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel.
Li X; Qiu W; Liu B; Yao R; Liu S; Yao Y; Liang J
J Transl Med; 2013 Sep; 11():204. PubMed ID: 24004449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
